Follow-up studies of patients implanted with native bioabsorbable polymer rapamycin-eluting stent

摘要：

Background To observe the recent clinical effects of native bioabsorbable polymer Rapamycin-eluting stent (Excel) for treating coronary heart disease (CHD).Methods From February 2007 to October 2008, a total of 127 consecutive patients with CHD who received Excel stent implantation,185 Excel stents were implanted in 152 criminal-related arteries.Followed-up was done for 3-6 months through outpatient department and telephone equipment.The major adverse cardiac events (MACE) including cardic death, non-fatal myocardial infarction or target vessel revascularization and clinical symptoms were the targets we wanted to observe.1.

作者: XU Yan-min LI Guang-ping YU Li-na

作者单位: Second Hospital of Tianjin Medical University,Tianjin,China

会议类型: 国内会议

会议名称: 第11届中国介入心脏病学大会

会议地点: 北京

会议语种:英文

页码: 153-153

在线出版日期: 2013-03-20（万方平台首次上网日期，不代表论文的发表时间）